Diana Cervantes-Madrid
3PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Dec 20, 2019
Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells.Diana Cervantes-Madrid, Joanna Szydzik, Dan Emil Lind
|Nov 22, 2018
Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways.Jimmy Van den Eynden, Ganesh Umapathy, Arghavan Ashouri
|Nov 30, 2017
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas.Ganesh Umapathy, Jikui Guan, Dan E Gustafsson
Pageof 1
Frequent Collaborators
3 joint publications
Bengt Hallberg
2 joint publications
Ganesh Umapathy
2 joint publications
Jikui Guan
2 joint publications
Dan Emil Lind
2 joint publications
Ruth H Palmer
1 joint publications
Niloufar Javanmardi
1 joint publications
Anna Djos
1 joint publications
Tommy Martinsson
1 joint publications
Jimmy Van den Eynden
1 joint publications
Arghavan Ashouri
